ProMIS Neurosciences, Inc. (PMN)

NASDAQ: PMN · IEX Real-Time Price · USD

1.985

+0.065 (3.39%)

At close: May 2, 2024, 4:00 PM

2.020

+0.035 (1.76%)

After-hours: May 2, 2024, 4:23 PM EDT

ProMIS Neurosciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020
Net Income	-13.21	-18.06	-9.79	-4.25
Depreciation & Amortization	0.02	0.01	0.05	0.01
Share-Based Compensation	0.27	0.49	0.52	0.35
Other Operating Activities	2.08	0.53	-0.08	0.65
Operating Cash Flow	-10.84	-17.03	-9.31	-3.23
Capital Expenditures	0	-0	0.09	-0.08
Change in Investments	-0	0	-0	-0
Other Investing Activities	-	-	0	-0
Investing Cash Flow	-0	-0	0.09	-0.08
Share Issuance / Repurchase	17.75	6.49	18.61	1.61
Debt Issued / Paid	0	0	6.92	0
Other Financing Activities	0	-	-	1.26
Financing Cash Flow	17.75	6.49	25.52	2.86
Exchange Rate Effect	-0.18	-0.53	-0.18	-0.02
Net Cash Flow	6.72	-11.07	16.14	-0.47
Free Cash Flow	-10.84	-17.04	-9.21	-3.31
Free Cash Flow Per Share	-0.88	-2.27	-1.59	-0.70

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).